Humana Inc. (NYSE:HUM) Shares Bought by Diversified Trust Co

Diversified Trust Co grew its position in shares of Humana Inc. (NYSE:HUM) by 30.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,709 shares of the insurance provider’s stock after purchasing an additional 627 shares during the period. Diversified Trust Co’s holdings in Humana were worth $939,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of HUM. Rakuten Securities Inc. acquired a new stake in shares of Humana during the 4th quarter worth about $25,000. Gradient Investments LLC boosted its position in shares of Humana by 200.0% in the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares during the last quarter. Cetera Trust Company N.A acquired a new stake in shares of Humana in the fourth quarter worth approximately $28,000. Private Wealth Management Group LLC acquired a new stake in shares of Humana in the fourth quarter worth approximately $32,000. Finally, Carolinas Wealth Consulting LLC boosted its position in shares of Humana by 274.1% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after acquiring an additional 74 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on HUM shares. UBS Group decreased their target price on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Piper Sandler began coverage on shares of Humana in a research report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price target on the stock. Bank of America lifted their price target on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research report on Monday, May 20th. Finally, Raymond James started coverage on shares of Humana in a research report on Friday, March 22nd. They set a “market perform” rating on the stock. Fourteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $409.55.

Humana Stock Down 0.0 %

Humana stock opened at $373.49 on Tuesday. The company has a 50-day simple moving average of $343.78 and a 200-day simple moving average of $351.23. The firm has a market capitalization of $45.01 billion, a P/E ratio of 23.26, a P/E/G ratio of 2.16 and a beta of 0.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana Inc. has a one year low of $298.61 and a one year high of $530.54.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $9.38 earnings per share. As a group, equities analysts expect that Humana Inc. will post 16.27 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 0.95%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.